• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于非裔美国癌症患者的癌症临床试验决策模型。

A Model of Cancer Clinical Trial Decision-making Informed by African-American Cancer Patients.

机构信息

Johns Hopkins School of Nursing, 525 N. Wolfe St, Baltimore, MD 21205-2110, USA.

Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

J Racial Ethn Health Disparities. 2015 Jun;2(2):192-9. doi: 10.1007/s40615-014-0063-x.

DOI:10.1007/s40615-014-0063-x
PMID:25960945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4420720/
Abstract

BACKGROUND

Clinical trials are critical to advancing cancer treatment. Minority populations are underrepresented among trial participants, and there is limited understanding of their decision-making process and key determinants of decision outcomes regarding trial participation.

METHODS

To understand research decision-making among clinical trial-eligible African-American cancer patients at Johns Hopkins, we conducted seven focus groups (n=32) with trial-offered patients ≥ 18 years diagnosed with lung, breast, prostate, or colorectal cancer ≤ 5 years. Three "acceptor" and four "decliner" focus groups were conducted. Questions addressed: attitudes towards clinical trials, reasons for accepting or declining participation, and recommendations to improve minority recruitment and enrollment. Data were transcribed and analyzed using traditional approaches to content and thematic analysis in NVivo 9.0. Data coding resulted in themes that supported model construction.

RESULTS

Participant experiences revealed the following themes when describing the decision-making process: Information gathering, Intrapersonal perspectives, and Interpersonal influences. Decision outcomes included the presence or absence of decision regret and satisfaction. From these themes, we generated a Model of Cancer Clinical Trial Decision-making.

CONCLUSION

Our model should be tested in hypothesis-driven research to elucidate factors and processes influencing decision balance and outcomes of trial-related decision-making. The model should also be tested in other disparities populations and for diagnoses other than cancer.

摘要

背景

临床试验对于推进癌症治疗至关重要。少数族裔人群在试验参与者中代表性不足,对于他们参与试验的决策过程和关键决定因素的理解有限。

方法

为了了解约翰霍普金斯大学符合条件的非洲裔美国癌症患者的研究决策,我们对 32 名年龄在 18 岁及以上、被诊断患有肺癌、乳腺癌、前列腺癌或结直肠癌且患病时间不超过 5 年的患者进行了 7 次焦点小组讨论。进行了 3 次“接受者”和 4 次“拒绝者”焦点小组。问题涉及:对临床试验的态度、参与或拒绝参与的原因,以及改善少数民族招募和参与的建议。使用 NVivo 9.0 中的传统内容分析和主题分析方法对转录数据进行分析。数据编码产生了支持模型构建的主题。

结果

参与者在描述决策过程时的经验揭示了以下主题:信息收集、个人观点和人际影响。决策结果包括是否存在决策后悔和满意度。从这些主题中,我们生成了癌症临床试验决策模型。

结论

我们的模型应在假设驱动的研究中进行测试,以阐明影响试验相关决策平衡和结果的因素和过程。该模型还应在其他差异人群和除癌症以外的诊断中进行测试。

相似文献

1
A Model of Cancer Clinical Trial Decision-making Informed by African-American Cancer Patients.基于非裔美国癌症患者的癌症临床试验决策模型。
J Racial Ethn Health Disparities. 2015 Jun;2(2):192-9. doi: 10.1007/s40615-014-0063-x.
2
Exploring Racial Disparities in Awareness and Perceptions of Oncology Clinical Trials: Cross-Sectional Analysis of Baseline Data From the mychoice Study.探索肿瘤学临床试验认知和观念方面的种族差异:mychoice 研究基线数据的横断面分析。
JMIR Cancer. 2024 Sep 30;10:e56048. doi: 10.2196/56048.
3
A systematic review of the factors influencing African Americans' participation in cancer clinical trials.一项系统评价影响非裔美国人参与癌症临床试验的因素。
Contemp Clin Trials. 2013 Jul;35(2):13-32. doi: 10.1016/j.cct.2013.03.007. Epub 2013 Apr 1.
4
Perceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: what do refusers say?非裔美国癌症患者对参与 I 期、II 期或 III 期临床试验的看法:拒绝者怎么说?
J Oncol Pract. 2013 Nov;9(6):287-93. doi: 10.1200/JOP.2013.001039. Epub 2013 Oct 15.
5
Increasing Clinical Trial Participation of Black Women Diagnosed with Breast Cancer.提高被诊断患有乳腺癌的黑人女性参与临床试验的比例。
J Racial Ethn Health Disparities. 2024 Jun;11(3):1701-1717. doi: 10.1007/s40615-023-01644-z. Epub 2023 Jun 14.
6
Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community-engaged development and pilot testing of a digital intervention.促进癌症黑人患者精准肿瘤学和临床试验参与的知情方法:数字干预措施的社区参与式开发和试点测试。
Cancer. 2024 Oct 15;130 Suppl 20(Suppl 20):3561-3577. doi: 10.1002/cncr.35049. Epub 2023 Oct 13.
7
The role of health literacy on African American and Hispanic/Latino perspectives on cancer clinical trials.健康素养对非裔美国人和西班牙裔/拉丁裔看待癌症临床试验的作用。
J Cancer Educ. 2012 Jun;27(2):299-305. doi: 10.1007/s13187-011-0300-5.
8
Psychosocial Factors That Influence a Woman's Decision to Enroll in a Clinical Trial: Implications on How to Improve Clinical Trial Enrollment Among Black Women.影响女性参与临床试验决策的心理社会因素:对如何提高黑种女性参与临床试验的启示。
Int J Radiat Oncol Biol Phys. 2024 Aug 1;119(5):1347-1356. doi: 10.1016/j.ijrobp.2024.02.017. Epub 2024 Feb 21.
9
Formative research to design a culturally-appropriate cancer clinical trial education program to increase participation of African American and Latino communities.开展形成性研究,设计一种文化上适宜的癌症临床试验教育计划,以增加非裔美国人和拉丁裔社区的参与度。
BMC Public Health. 2020 Jun 3;20(1):840. doi: 10.1186/s12889-020-08939-4.
10
Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.理解癌症临床试验参与者参与研究的决策:与知情同意、患者满意度和决策后悔相关的因素。
Patient Educ Couns. 2006 Oct;63(1-2):104-9. doi: 10.1016/j.pec.2005.09.006. Epub 2005 Oct 19.

引用本文的文献

1
A Formative Evaluation of Interventions to Enhance Clinical Trial Diversity Guided by the Socioecological Model.以社会生态模型为指导的增强临床试验多样性干预措施的形成性评估。
Cancers (Basel). 2025 Jul 9;17(14):2282. doi: 10.3390/cancers17142282.
2
Understanding Inclusion and Participation of People From Black African Diaspora Communities in Health and Care Research: A Realist Review.理解非洲黑人散居社区人群在健康与护理研究中的纳入与参与:一项实在论综述
Health Expect. 2025 Jun;28(3):e70298. doi: 10.1111/hex.70298.
3
Winning hearts & minds: prostate cancer outreach and clinical trial enrollment in minority men.赢得人心:少数族裔男性的前列腺癌宣传与临床试验招募
Transl Cancer Res. 2024 Nov 30;13(11):6430-6437. doi: 10.21037/tcr-24-868. Epub 2024 Oct 10.
4
Exploring Racial Disparities in Awareness and Perceptions of Oncology Clinical Trials: Cross-Sectional Analysis of Baseline Data From the mychoice Study.探索肿瘤学临床试验认知和观念方面的种族差异:mychoice 研究基线数据的横断面分析。
JMIR Cancer. 2024 Sep 30;10:e56048. doi: 10.2196/56048.
5
Associations Between Race/Ethnicity, Language, and Enrollment on Cancer Research Studies.种族/民族、语言与癌症研究项目入组之间的关联。
Oncologist. 2023 Feb 8;28(2):131-138. doi: 10.1093/oncolo/oyac218.
6
Diversity of Participation in Clinical Trials and Influencing Factors: Findings from the Health Information National Trends Survey 2020.参与临床试验的多样性及其影响因素:来自 2020 年健康信息国家趋势调查的发现。
J Gen Intern Med. 2023 Mar;38(4):961-969. doi: 10.1007/s11606-022-07780-2. Epub 2022 Sep 22.
7
Behavioural approaches to recruitment and retention in clinical trials: a systematic mapping review.行为学方法在临床试验招募和保留中的应用:系统综述。
BMJ Open. 2022 Mar 9;12(3):e054854. doi: 10.1136/bmjopen-2021-054854.
8
African American participation in cancer clinical trials.非裔美国人参与癌症临床试验的情况。
Ecancermedicalscience. 2021 Oct 25;15:1307. doi: 10.3332/ecancer.2021.1307. eCollection 2021.
9
Update to 2019-2022 ONS Research Agenda: Rapid Review to Address Structural Racism and Health Inequities.更新至 2019-2022 年 ONS 研究议程:快速审查以解决结构性种族主义和健康不平等问题。
Oncol Nurs Forum. 2021 Nov 1;48(6):589-600. doi: 10.1188/21.ONF.589-600.
10
Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design.采用移动医疗决策辅助工具改善晚期前列腺癌患者及其决策伙伴/代理人的决策:CHAMPION 随机对照试验研究设计。
Trials. 2021 Sep 16;22(1):631. doi: 10.1186/s13063-021-05602-0.

本文引用的文献

1
A systematic review of the factors influencing African Americans' participation in cancer clinical trials.一项系统评价影响非裔美国人参与癌症临床试验的因素。
Contemp Clin Trials. 2013 Jul;35(2):13-32. doi: 10.1016/j.cct.2013.03.007. Epub 2013 Apr 1.
2
Does enrollment in cancer trials improve survival?癌症临床试验的参与是否能改善生存?
J Am Coll Surg. 2013 Apr;216(4):774-80; discussion 780-1. doi: 10.1016/j.jamcollsurg.2012.12.036. Epub 2013 Feb 13.
3
Cancer support and resource needs among African American older adults.非裔美国老年人的癌症支持与资源需求
Clin J Oncol Nurs. 2012 Aug;16(4):372-7. doi: 10.1188/12.CJON.372-377.
4
The role of health literacy on African American and Hispanic/Latino perspectives on cancer clinical trials.健康素养对非裔美国人和西班牙裔/拉丁裔看待癌症临床试验的作用。
J Cancer Educ. 2012 Jun;27(2):299-305. doi: 10.1007/s13187-011-0300-5.
5
Cognitive and affective correlates of decisional balance regarding screening mammography in older women.老年女性筛查性乳房 X 光检查决策平衡的认知和情感相关性。
Psychol Health Med. 2012;17(2):164-75. doi: 10.1080/13548506.2011.596550. Epub 2011 Jul 25.
6
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.癌症统计数据,2011 年:消除社会经济和种族差异对癌症过早死亡的影响。
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17.
7
The validity of self-reported cancer diagnoses and factors associated with accurate reporting in a cohort of older Australian women.澳大利亚老年女性队列中自我报告癌症诊断的有效性及与准确报告相关的因素。
Cancer Epidemiol. 2011 Dec;35(6):e75-80. doi: 10.1016/j.canep.2011.02.005. Epub 2011 Apr 6.
8
Analysis of Maryland cancer patient participation in National Cancer Institute-supported cancer treatment clinical trials.马里兰州癌症患者参与美国国立癌症研究所资助的癌症治疗临床试验情况分析。
J Health Care Poor Underserved. 2009 May;20(2 Suppl):120-34. doi: 10.1353/hpu.0.0162.
9
American society of clinical oncology policy statement: disparities in cancer care.美国临床肿瘤学会政策声明:癌症治疗中的差异
J Clin Oncol. 2009 Jun 10;27(17):2881-5. doi: 10.1200/JCO.2008.21.1680. Epub 2009 Apr 29.
10
Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials.拒绝参与随机临床化疗试验的晚期非小细胞肺癌患者的特征与结局
Br J Cancer. 2009 Apr 7;100(7):1037-42. doi: 10.1038/sj.bjc.6604982. Epub 2009 Mar 17.